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Abstract
Background: Prevalence of asthma and allergies in top athletes is high. However, most previous studies did not
include a general population comparison group. We aimed to compare the prevalence of asthma, allergies and
medical treatment in different groups of German top athletes to the general population.
Methods: Prior to the 2008 Summer Olympic Games, 291 German candidates for participation (65%) completed a
questionnaire on respiratory and allergic symptoms. Results were compared to those of a general population study
in Germany (n = 2425, response 68%). Furthermore, associations between types of sports and the self-reported
outcomes were calculated. All models were adjusted for age, sex, level of education and smoking.
Results: Athletes reported significantly more doctors’ diagnosed asthma (17% vs. 7%), more current use of asthma
medication (10% vs. 4%) and allergic rhinitis (25% vs. 17%) compared to the general population. After adjustment,
top athletes only had an increased Odds Ratio for doctor’s diagnosed asthma (OR: 1.6; 95% CI 1.1-2.5). Compared
to the general population, athletes in endurance sports had an increased OR for doctor’s diagnosed asthma (2.4;
1.5-3.8) and current use of asthma medication (1.8; 1.0-3.4). In this group, current wheeze was increased when use
of asthma medication was taken into account (1.8; 1.1-2.8). For other groups of athletes, no significantly increased
ORs were observed.
Conclusions: Compared to the general population, an increased risk of asthma diagnosis and treatment was
shown for athletes involved in endurance sports. This might be due to a better medical surveillance and treatment
of these athletes.
Background
Allergies and asthma are frequent in elite athletes. Pre-
vious studies have shown that the prevalence of allergic
rhinitis in elite athletes is between 15% and 29% [1-5]
and that wheezing is reported by 6% to 15% of athletes
[2,3,6]. The prevalence of asthma in athletes was
reported to be different, based on the methods used and
the athletes included in the study. E.g., in the US, the
prevalence differed from 12% among athletes (football
players) in 1984 to 15% among athletes participating in
the 1996 Olympic Summer Games and up to 22%
among athletes who participated in the 1998 Olympic
Winter Games [2,7,8]. In Australia the prevalence of
diagnosed asthma in Olympic athletes rose from 10% in
1976 up to 21% in 2000 [9]. A five-year follow-up in
Finnish swimmers showed that prevalence of current
asthma increased from 31% at baseline to 44% at follow-
up [10]. Overall, between 7-18% of top athletes seem to
use asthma medication [4,7,11-13].
In comparison to non-athletes (medical students,
volunteers, general population sample), some earlier stu-
dies have observed a higher prevalence of asthma and
allergies in top athletes [3,6,13-16]. However, a recent
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Australian study could not show such differences
between the prevalence of asthma among athletes and
the general population [12].
Results of previous studies in top athletes indicated
that the prevalence of asthma is associated with specific
types of sport. Self-reported and doctors diagnosed
asthma was most common in athletes in endurance
sports like swimming, cycling and cross-country skiing
[2,5,6,12-14,16-18]. Furthermore, some studies observed
that medical treatment for asthma is also higher in ath-
letes in endurance sports [5,11,13]. In comparison to
other athletes, those performing in endurance sports
might be at higher risk as they inhale a large amount of
allergens and irritants (e.g. swimmers are exposed to
chlorine and chloramine) and because the ventilation is
increased for a longer period of time [15,19,20].
The knowledge about asthma and allergies in top ath-
letes is essential as the diseases influencing the perfor-
mance of the athletes. Furthermore, therapy during
training and competition has to be optimised. However,
some asthma medications are bounded to the anti-
doping regulations. Therefore, athletes who need to use
inhaled b2-agonists (e.g. Formoterol, Terbutalin) have to
be diagnosed with current asthma using standardized
protocols to obtain a therapeutic use exemption (TUE)
from the grating anti-doping Organizations (e.g.
National-Anti-Doping-Organization, International Sport
Federation, International Olympic Committee) [21-23].
So far, no data on German top athletes are available.
Therefore, one aim of the study was to assess the preva-
lence of allergic and respiratory diseases and informa-
tion about medical treatment in German top athletes.
Furthermore, we compared the prevalence of self-
reported asthma symptoms, allergies and medical treat-
ment in German top athletes to the general population
in Germany. In addition, we estimated the associations
between types of sports and level of endurance and the
self-reported outcomes. These results should help to
define which groups of German athletes are at increased
risk for asthma and allergies and to provide some
insights in the quality of asthma surveillance in athletes
and non-athletes.
Methods
Study design and participants
Within the framework of the Global Asthma and
Allergy European Networks (GA2LEN) [24], a cross sec-
tional study was conducted in several European coun-
tries to examine the prevalence of asthma and allergies
in participants of the Olympic Summer Games in
Beijing. Eligible participants were asked to complete the
Allergy Questionnaire for Athletes (AQUA) [25], a ques-
tionnaire for screening asthma and allergies in top
athletes.
Potential candidates were contacted by the German
Olympic Sports Federation between March to June
2008 prior to the beginning of the Olympic Games
in Beijing. All those eligible received a letter explain-
ing the study, a written informed consent form and
the questionnaire. Overall, 291 of about 450 German
top athletes completed the questionnaire (response
65%).
The study was approved by the Ethics Committee of
the Medical Faculty of the Ludwig-Maximilians-Univer-
sity Munich (071/08).
General population study
The participants of the general population were
recruited within the German Lower Saxony Lung Study
(NiLS), a survey that was done in 2002-2004 [26]. Over
ten thousand inhabitants (age 18 to 44 years) of four
rural towns were invited to answer a mail-in question-
naire. Those without occupational or private farm ani-
mal contact (n = 2425, response 68%) were considered
as representative general population comparison group
for the athletes.
Study instruments
To allow a comparison to the group of the general
population in Germany, besides the AQUA question-
naire [25] (top athletes only), additional questions from
the ECHRS (European Community Respiratory Health
Survey) questionnaire [27] were used in both studies.
These validated questions included symptoms of asthma,
allergies and medical treatment as well as socio-
demographic data.
Based on the questionnaire results, the following out-
comes were defined:
▪ Current wheeze: Have you had wheezing or whis-
tling in your chest at any time in the last 12
months?
▪ Doctor’s diagnosed asthma: Have you ever had
asthma? AND Was this confirmed by a doctor?
▪ Current use of asthma medication: Are you cur-
rently taking any medicines including inhalers, aero-
sols or tablets for asthma?
▪ Allergic rhinitis: Do you have any nasal allergies,
including hay fever?
▪ Current wheeze or use of asthma medication: In
order to assess whether control of asthma symptoms
might be better in asthmatic athletes than in the
general population, current wheeze and current use
of asthma medication were combined as an addi-
tional outcome.
To investigate if the prevalence of asthma, allergies
and medical treatment differ between different sport
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categories, type of sport was classified in accordance to
Alaranta et al. [13] into one of the following groups:
▪ Endurance sport: water sports, track and field ath-
letics, canoeing, cycling, rowing
▪ Team Sports: basketball, hockey, football, handball,
volleyball
▪ Motor Skills Sports: archery, gymnastics, shooting
▪ Others: Badminton, riding, fencing, judo, karate,
sailing, table tennis, taekwondo, wrestling
As level of endurance might have an own impact on
respiratory symptoms, we additionally classified the ath-
letes into three groups (classification by two medical
experts: B.W., F.E.):
▪ low/middle level of endurance: riding, gymnastics,
taekwondo, table tennis, shooting, archery, sailing
▪ high level of endurance: basketball, hockey, football,
handball, volleyball, fencing, judo, karate, wrestling,
▪ very high level of endurance: water sports, track
and field athletics, canoeing, cycling, rowing,
throwing,
Potential confounders
Age, sex, level of education and smoking as potential
confounding variables were dichotomised into:
▪ Smoking: never vs. ever
▪ Level of education: <12 years of education vs. ≥12
years of schooling,
▪ Age: mean of distribution (< vs. ≥32 years).
Statistical analysis
Chi2-tests were used to assess bivariate associations.
Multivariate analyses were done using logistic regression
models. We used three different exposure variables for
the models. The first model investigated differences of
the outcome variables between top athletes and the gen-
eral population. In the second analysis, the prevalence of
self-reported outcomes were compared from different
sport groups as defined above. The last model classified
the athletes according to their endurance level.
All models used the general population as reference cate-
gory adjusting for age, sex, level of education, and smoking.
Statistical analyses were carried out using SAS (SAS
version 9.1; SAS Institute Inc., Cary, NC, USA).
Results
Descriptives
In comparison to the general population top athletes
were more likely to have a higher level of education
(80% vs. 25%), to be under the age of 32 years (85% vs.
46%) and never have smoked (86% vs. 41%) than the
general population (table 1).
Dividing the athletes into different sport categories,
most of the athletes were involved in endurance sport
(48%) followed by team sports (25%). Only 10% did
sports requiring motor skills. The majority of the ath-
letes were classified as having a very high (46%) or high
(40%) endurance level.
Prevalence of asthma, allergies and medical treatment
Regarding asthma, allergies and medical treatment, top
athletes were more likely to report doctor’s diagnosed
asthma (17% vs. 7%), use of asthma medication (10% vs.
4%) and hay fever (25% vs. 17%) than the participants of
the general population (table 1). No statistically signifi-
cant difference was seen in the prevalence of asthma
symptoms.
Regarding the different sport categories, those in
endurance sports had the highest prevalence of diag-
nosed asthma (21%), followed by team sports (13%).
Medical treatment against asthma (12%), wheezing
(16%) and current wheezing or use of asthma medica-
tion (21%) was also most frequent in endurance athletes.
Only hay fever was highest in other sports (29%) fol-
lowed by team sports (25%) (table 1).
Athletes with a very high level of endurance showed
the highest prevalence for all observed outcomes (data
not shown).
Logistic regression models: top athletes vs. general
population
After adjusting, a statistically significantly increased risk
for doctor’s diagnosed of asthma (OR 1.6; 95% CI 1.1-
2.5) was seen for the top athletes. Regarding the other
outcomes, no statistically significant differences were
found between top athletes and the general population
(table 2).
Logistic regression models: Sports categories and
endurance level
Dividing the top athletes into different sport categories,
those in endurance sports had a statistically significantly
increased Odds Ratio for doctor’s diagnosed asthma
(2.4; 1.5-3.8), current use of asthma medication (1.8;
1.0-3.4) and current wheeze or use of asthma medica-
tion (1.8; 1.1-2.8) compared to the general population
(table 3). In contrast, no differences were shown with
respect to asthma symptoms or allergic rhinitis.
Analysis based on grouping by endurance levels
showed comparable results: those with a very high
endurance level had a statistically significantly increased
OR for doctor’s diagnosed asthma (2.5; 1.5-4.0), current
use of asthma medication (1.9; 1.0-3.5) and current
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wheeze or use of asthma medication (1.9 1.2-3.0). As for
type of sport, no associations between level of endur-
ance and symptoms were seen (table 3).
Discussion
This study is the first to report results about asthma,
allergies and medical treatment in different groups of
German top athletes compared to the general popula-
tion. We found a higher prevalence of doctor’s diag-
nosed asthma in athletes than in the general German
population. In addition, we found the highest prevalence
of doctor’s diagnosed asthma, current use of asthma
medication and current wheeze or use of asthma medi-
cation in athletes performing in endurance sports.
Furthermore, those athletes with a very high endurance
level also had a higher prevalence of the three outcomes
than the general population.
Seventeen percent of the German top athletes
reported a doctor diagnosis of asthma. Similar results
were observed in Denmark (16%), Canada (15%), Italy
(15%) and in US Summer Olympic athletes where 15%
reported doctor’s diagnosed asthma [2-4,11]. However,
the prevalence was lower than in the UK (21%), Finland
(23%) or Australia (26%) [12,15,17]. The prevalence of
allergic rhinitis in our study (25%) was quite similar to
those in Finnish swimmers (29%) [5] and in Canadian
athletes (21%) [4], but higher than in two studies from
Switzerland (17% [1]) and Italy (15%[3]). In addition, the
prevalence of wheezing in our study (12%) was similar
to results of an US study (10% [2]), but two-times
higher in comparison to the results of a Norwegian and
an Italian study where only 6% of the athletes reported
wheezing [3,6]. Ten percent of the participating athletes
reported current use of an asthma medication. This
result was in accordance with the majority of other stu-
dies that also investigated the use of asthma medication
in athletes [2,4,12,13].
Two previous studies showed that athletes had an
increased risk for allergic symptoms such as allergic rhi-
nitis in comparison to non-athletes [15,28]. We could
not confirm these findings. However, as in previous stu-
dies [3,13-16], prevalence of asthma diagnosis was
higher in top athletes than in the general population. In
general, this might be due to a better medical surveil-
lance of the athletes. Another explanation for the lower
prevalence in the general population might be that the
participants lived mainly at the countryside and it is
known that the prevalence of asthma and allergies is
lower in these people [26]. Furthermore, it has to be
kept in mind that the survey was done 5 years prior to
the AQUA-survey, however, it has been recently shown
that prevalence of asthma and allergies reached a pla-
teau. As we had to rely on self-reported data it might
also be that the reported respiratory symptoms of the
athletes during and/or after exercise might be misinter-
preted as asthma and could be just exercise-related
symptoms.
Athletes performing in endurance sports and those
with a very high endurance level also had a significantly
increased risk for current use of asthma medication (1.8;
1.0-3.4) and current wheezing or use of asthma
Table 1 Prevalence of allergic rhinitis, respiratory symptoms and asthma treatment by population group and
sports category
Variable N (%) General population Top athletes Endurance Motor Skills Team Sports Others
N = 2425 N = 291 N = 140 N = 28 N = 72 N = 51
Age (<32 years) 1110 (45.8) 248 (85.2)* 122 (85.7) 18 (64.3) 67 (93.1) 40 (78.4)
Education
(> = 12 years of schooling)
608 (25.1) 232 (79.7)* 112 (80.1) 17 (60.7) 63 (87.5) 39 (76.5)
Smoking (never) 1001 (41.3) 247 (86.1)* 126 (92.0) 19 (67.9) 63 (90.0) 38 (74.5)
Allergic rhinitis (ever) 409 (16.9) 71 (25.4)* 34 (24.3) 4 (14.2) 18 (25.0) 15 (29.4)
Current wheeze 322 (13.3) 34 (12.0) 23 (16.4) 1 (3.6) 5 (6.9) 4 (7.8)
Doctor’s diagnosed asthma (ever) 174 (7.2) 47 (16.6)* 30 (21.4) 2 (7.1) 9 (12.5) 5 (9.8)
Current use of asthma medication 94 (3.9) 27 (9.5)* 17 (12.1) 1 (3.6) 8 (11.1) 3 (5.9)
Current wheeze or use of asthma medication 348 (14.4) 44 (15.6) 29 (20.7) 2 (7.1) 6 (8.3) 4 (7.8)
*pChi ² < 0.05
Table 2 Adjusted Odds Ratios with 95% Confidence




Allergic rhinitis (ever) 1.1 (0.8-1.5)
Current wheeze 0.9 (0.6-1.4)
Doctor’s diagnosed asthma 1.6 (1.1-2.5)
Current use of asthma medication 1.4 (0.8-2.3)
Current wheeze or use of asthma medication 1.1 (0.8-1.6)
Reference group: general population (OR = 1)
OR: Odds Ration; CI: Confidence Interval
* adjusted for age, sex, level of education and smoking
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medication (1.8; 1.1-2.8). Athletes of the remaining sport
types did not differ from to the general population. An
explanation for a higher prevalence of asthma in athletes
performing endurance sports and those with a very high
endurance level might be that these athletes expose
their airways to allergens and irritants and their ventila-
tion rate is increased for a longer period of time
[19,20,29]. The results indicate that those athletes who
have the highest risk for an asthma diagnosis are well
monitored by the clinicians and are treated sufficiently
against asthma. The control of asthma and the appropri-
ate medical treatment is indispensable to avoid a reduc-
tion of the performance of the athletes. However, no
dose-response relationship between endurance level and
respiratory health was found.
One strength of this study was that we were able to
divide the athletes into different groups regarding their
endurance levels. This is of importance considering that
within the different sports discipline groups the athletes
are showing up with relevant differences in endurance
levels. However, we were not able to assess possible risks
of single sport groups e.g. swimmers or soccer players
because the numbers in these groups were too small.
A limitation of our study was the data collection using
a self-administered questionnaire. Thus, objective clinical
data are missing to underline the observed results. How-
ever, validated questions were used and the chance of
over reporting is limited as the prevalence of symptoms
was not increased. The response of 65% was moderate
but comparable to many other populations-based studies.
Conclusions
Taking socio-demographic differences and smoking
habits between top athletes and the general population
into account, our study suggest that medical surveillance
and treatment in Germany especially in top athletes
involved in endurance sports is better than in the gen-
eral population.
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